4.6 Article

C18 ORF1, a Novel Negative Regulator of Transforming Growth Factor- β Signaling

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 289, 期 18, 页码 12680-12692

出版社

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M114.558981

关键词

Activin; EMT; Receptor Serine; threonine Kinase; SMAD Transcription Factor; Transforming Growth Factor (TGF); C18ORF1; SARA; SIM; TMEPAI

资金

  1. Ministry of Education, Culture, Sports, Science, and Technology of Japan
  2. Japan Society for the Promotion of Science
  3. MEXT
  4. Takeda Science Foundation
  5. Smoking Research Foundation
  6. Daiichi-Sankyo Foundation of Life Science
  7. Naito Foundation
  8. Vehicle Racing Commemorative Foundation
  9. Showa Pharmaceutical University
  10. Joint Usage/Research Program of the Medical Research Institute
  11. Tokyo Medical and Dental University
  12. Grants-in-Aid for Scientific Research [26305006, 23689023, 25118728, 25670168] Funding Source: KAKEN

向作者/读者索取更多资源

Background: The structure of C18ORF1 is similar to that of TMEPAI. Results: C18ORF1 inhibits TGF- signaling, but not BMP signaling, by its competition with SARA for Smad2/3 binding. Conclusion: C18ORF1 is a surveillant during the steady state of TGF- signaling, although it is helped by TMEPAI to inhibit TGF- signaling in a coordinated manner. Significance: C18ORF1 acts as a gatekeeper that abrogates excessive TGF- signaling. Transforming growth factor (TGF)- signaling is deliberately regulated at multiple steps in its pathway from the extracellular microenvironment to the nucleus. However, how TGF- signaling is activated or attenuated is not fully understood. We recently identified transmembrane prostate androgen-induced RNA (TMEPAI), which is involved in a negative feedback loop of TGF- signaling. When we searched for a family molecule(s) for TMEPAI, we found C18ORF1, which, like TMEPAI, possesses two PY motifs and one Smad-interacting motif (SIM) domain. As expected, C18ORF1 could block TGF- signaling but not bone morphogenetic protein signaling. C18ORF1 bound to Smad2/3 via its SIM and competed with the Smad anchor for receptor activation for Smad2/3 binding to attenuate recruitment of Smad2/3 to the TGF- type I receptor (also termed activin receptor-like kinase 5 (ALK5)), in a similar fashion to TMEPAI. Knockdown of C18ORF1 prolonged duration of TGF--induced Smad2 phosphorylation and concomitantly potentiated the expression of JunB, p21, and TMEPAI mRNAs induced by TGF-. Consistently, TGF--induced cell migration was enhanced by the knockdown of C18ORF1. These results indicate that the inhibitory function of C18ORF1 on TGF- signaling is similar to that of TMEPAI. However, in contrast to TMEPAI, C18ORF1 was not induced upon TGF- signaling. Thus, we defined C18ORF1 as a surveillant of steady state TGF- signaling, whereas TMEPAI might help C18ORF1 to inhibit TGF- signaling in a coordinated manner when cells are stimulated with high levels of TGF-.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据